-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On Innoviva with Overweight Rating, Announces Price Target of $29

Benzinga·11/18/2026 12:29:07
Diffusion vocale
Piper Sandler analyst David Amsellem initiates coverage on Innoviva (NASDAQ:INVA) with a Overweight rating and announces Price Target of $29.